Epinephrine
Reason Lack of Assurance of Sterility
Yes — there is an active recall. 82 ongoing FDA recalls mention Pine (685 total). Check the affected lots below.
Recalls are matched by product description. A recall usually affects specific lots, not every package of Pine. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed.
Reason Lack of Assurance of Sterility
Reason Lack of Assurance of Sterility
Reason Lack of Processing Controls
Reason Lack of Processing Controls
Reason Stability Does Not Support Expiry: manufactured with an active ingredient that expired before the labeled Beyond Use Date.
Reason Stability Does Not Support Expiry: manufactured with an active ingredient that expired before the labeled Beyond Use Date.
Reason Stability Does Not Support Expiry: manufactured with an active ingredient that expired before the labeled Beyond Use Date.
Reason Lack of Assurance of Sterility: incomplete or missing data regarding production.
Reason Lack of Assurance of Sterility: incomplete or missing data regarding production.
Reason Superpotent Drug: one ingredient was found to be above assay specification.
Reason CGMP Deviations: finished products manufactured using active pharmaceutical ingredients whose intermediates failed specifications.
Reason CGMP Deviations: finished products manufactured using active pharmaceutical ingredients whose intermediates failed specifications.
Reason Lack of Assurance of Sterility
Reason Subpotent Drug; confirmed results by FDA analysis after customer complaints of discoloration
Reason Subpotent Drug; confirmed results by FDA analysis after customer complaints of discoloration
Reason Presence of particulate matter: Presence of silicone oil microdroplets in bevacizumab syringes for intravitreal use.
Reason Presence of particulate matter: Presence of silicone oil microdroplets in bevacizumab syringes for intravitreal use.
Reason Presence of particulate matter: Presence of silicone oil microdroplets in bevacizumab syringes for intravitreal use.
Reason Presence of particulate matter: Presence of silicone oil microdroplets in bevacizumab syringes for intravitreal use.
Reason Defective Delivery System; potential to have inaccurate dosage delivery
Reason Defective Delivery System; potential to have inaccurate dosage delivery
Reason Labeling: Not elsewhere classified - Product label incorrectly lists Scopolamine Hydrocodone as an active ingredient on the side panel instead of Scopolamine Hydrobromide.
Reason Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.
Reason Subpotent Drug
Reason Discoloration
Tell us which medications you take. If the FDA recalls one, we email you - in plain English, with what to do. Free.